慢性阻塞性肺疾病流行病学研究进展

查震球

doi:10.19837/j.cnki.ahyf.2022.03.001

PDF(875 KB)

安徽预防医学杂志 ›› 2022, Vol. 28 ›› Issue (3) : 171-176. DOI: 10.19837/j.cnki.ahyf.2022.03.001

专家约稿

慢性阻塞性肺疾病流行病学研究进展

查震球

作者信息 +

Research progress in the epidemiology of chronic obstructive pulmonary disease

ZHA Zhen-qiu

Author information +

文章历史 +

摘要

慢性阻塞性肺疾病已经成为全球性公共卫生问题。近年来,有关该病的流行病学研究较多,由于各个国家地区人文环境、地理环境、经济因素等方面的不同,使得慢性阻塞性疾病的流行病学特征存在较大差异。本文主要从慢性阻塞性肺疾病的流行特征、相关的危险因素以及疾病负担等方面进行综述。

Abstract

Chronic obstructive pulmonary disease (COPD) has become a global public health problem.In recent years,more and more attention has been paid to the COPD epidemiology.Due to the differences in human culture,geographical environment,economic factors and other issues in different countries and regions,there are great variances in the epidemiological characteristics of COPD.This article mainly reviews the epidemic characteristics,related risk factors and disease burden of COPD.

导出引用

查震球. 慢性阻塞性肺疾病流行病学研究进展[J]. 安徽预防医学杂志. 2022, 28(3): 171-176 https://doi.org/10.19837/j.cnki.ahyf.2022.03.001

ZHA Zhen-qiu. Research progress in the epidemiology of chronic obstructive pulmonary disease[J]. Anhui Journal of Preventive Medicine. 2022, 28(3): 171-176 https://doi.org/10.19837/j.cnki.ahyf.2022.03.001

中图分类号： R56

参考文献

[1] Global Initiative for Chronic Obstructive Lung Disease (GOLD).Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease (2022 report)[EB/OL].[2022-1-21].https://goldcopd.org/2022-gold-reports-2/.
[2] GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet (London,England),2020,396(10258):1204-1222.DOI:10.1016/S0140-6736(20)30925-9.
[3] World Health Organization.Global Health Estimates:Life expectancy and leading causes of death and disability[EB/OL].[2022-1-21].https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates.
[4] McDonough JE,Yuan R,Suzuki M,et al.Small-airway obstruction and emphysema in chronic obstructive pulmonary disease[J].N Engl J Med,2011,365(17):1567-1575.
[5] Kim V,Crapo J,Zhao H,et al.Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene[Z].2015,12(3),332-339.
[6] Krahnke JS,Abraham WT,Adamson PB,et al.Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device[J].J Card Fail,2015,21(3):240-249.DOI:10.1016/j.cardfail.2014.12.008.
[7] Ge H,Liu X,Gu W,et al.Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score:Results from SCICP[J].J Inflamm Res,2021,14:3335-3348.DOI:10.2147/JIR.S315600.
[8] Shen E,Lee JS,Mularski RA,et al.COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use[J].Chest,2021,159(6):2233-2243.DOI:10.1016/j.chest.2021.01.020.
[9] Ding Z,Wang K,Li J,et al.Association between glutathione S-transferase gene M1 and T1 polymorphisms and chronic obstructive pulmonary disease risk:A meta-analysis[J].Clin Genet,2019,95(1):53-62.DOI:10.1111/cge.13373.
[10] Agusti A,Faner R.Lung function trajectories in health and disease[Z].2019,7(4):358-364.
[11] GBD Chronic Respiratory Disease Collaborators.Prevalence and attributable health burden of chronic respiratory diseases,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet Respir Med,2020,8(6):585-596.DOI:10.1016/S2213-2600(20)30105-3.
[12] Ho T,Cusack RP,Chaudhary N,et al.Under- and over-diagnosis of COPD:a global perspective[J].Breathe (Sheffield,England),2019,15(1):24-35.DOI:10.1183/20734735.0346-2018.
[13] Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study):a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.DOI:10.1016/S0140-6736(18)30841-9.
[14] Fang L,Gao P,Bao H,et al.Chronic obstructive pulmonary disease in China:a nationwide prevalence study[J].Lancet Respir Med,2018,6(6):421-430.DOI:10.1016/S2213-2600(18)30103-6.
[15] World Health Organization.Projections of mortality and causes of death,2017 and 2060[EB/OL].[2022-2-11].https://www.who.int/healthinfo/global_burden_disease/projections_method.pdf.
[16] Wheaton AG,Liu Y,Croft JB,et al.Chronic Obstructive Pulmonary Disease and Smoking Status - United States,2017[J].MMWR Morb Mortal Wkly Rep,2019,68(24):533-538.DOI:10.15585/mmwr.mm6824a1.
[17] Blanco I,Diego I,Bueno P,et al.Geographical distribution of COPD prevalence in Europe,estimated by an inverse distance weighting interpolation technique[J].Int J Chron Obstruct Pulmon Dis,2018,13:57-67.DOI:10.2147/COPD.S150853.
[18] Wang N,Cong S,Fan J,et al.Geographical Disparity and Associated Factors of COPD Prevalence in China:A Spatial Analysis of National Cross-Sectional Study[J].Int J Chron Obstruct Pulmon Dis,2020,15:367-377.DOI:10.2147/COPD.S234042.
[19] Verma A,Gudi N,Yadav UN,et al.Prevalence of COPD among population above 30 years in India:A systematic review and meta-analysis[J].J Glob Health,2021,11:4038.DOI:10.7189/jogh.11.04038.
[20] Zha Z,Leng R,Xu W,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province,China:a population-based survey[J].BMC Pulm Med,2019,19(1):102.DOI:10.1186/s12890-019-0864-0.
[21] Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):753-760.DOI:10.1164/rccm.200612-1749OC.
[22] 金航,章文强,马新雅,等.四川省城乡慢性阻塞性肺病患病率及影响因素分析[J].预防医学情报杂志,2021,37(4):465-471.
[23] 罗倩,王晓园,张海涛,等.新疆乌鲁木齐市城乡40岁以上居民慢性阻塞性肺疾病的患病情况与相关危险因素分析[J].临床肺科杂志,2019,24(9):1562-1567.
[24] 殷蕾,黄跃龙,金东辉,等.湖南省40岁及以上居民慢性阻塞性肺疾病患病情况及影响因素分析[J].中国慢性病预防与控制,2020,28(10):731-734.
[25] Adeloye D,Chua S,Lee C,et al.Global and regional estimates of COPD prevalence:Systematic review and meta-analysis[J].J Glob Health,2015,5(2):2041.DOI:10.7189/jogh.05-020415.
[26] Ntritsos G,Franek J,Belbasis L,et al.Gender-specific estimates of COPD prevalence:a systematic review and meta-analysis[J].Int J Chron Obstruct Pulmon Dis,2018,13:1507-1514.DOI:10.2147/COPD.S146390.
[27] 张雍,汤洪秀,周琦,等.重庆市渝中区成年居民慢性阻塞性肺疾病患病情况及影响因素研究[J].重庆医学,2019,48(24):4226-4230.
[28] Delmas M,Bénézet L,Ribet C,et al.Underdiagnosis of obstructive lung disease:findings from the French CONSTANCES cohort[Z].2021,21,319.
[29] GBD 2016 Causes of Death Collaborators.Global,regional,and national age-sex specific mortality for 264 causes of death,1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1151-1210.DOI:10.1016/S0140-6736(17)32152-9.
[30] 中国疾病预防控制中心慢性非传染性疾病预防控制中心,国家卫生健康委统计信息中心.中国死因监测数据集(2019)[M].北京:中国科学技术出版社,2020.
[31] 陈亚红.2017年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读[J].中国医学前沿杂志(电子版),2017,9(1):11.
[32] Joehanes R,Just AC,Marioni RE,et al.Epigenetic Signatures of Cigarette Smoking[J].Circ Cardiovasc Genet,2016,9(5):436-447.DOI:10.1161/CIRCGENETICS.116.001506.
[33] Imboden M,Wielscher M,Rezwan FI,et al.Epigenome-wide association study of lung function level and its change[J].Eur Respir J,2019,54(1):1900457.DOI:10.1183/13993003.00457-2019.
[34] Forey BA,Thornton AJ,Lee PN.Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD,chronic bronchitis and emphysema[J].BMC Pulm Med,2011,11:36.DOI:10.1186/1471-2466-11-36.
[35] Diver WR,Jacobs EJ,Gapstur SM.Secondhand Smoke Exposure in Childhood and Adulthood in Relation to Adult Mortality Among Never Smokers[J].Am J Prev Med,2018,55(3):345-352.DOI:10.1016/j.amepre.2018.05.005.
[36] He Y,Jiang B,Li LS,et al.Secondhand smoke exposure predicted COPD and other tobacco-related mortality in a 17-year cohort study in China[J].Chest,2012,142(4):909-918.DOI:10.1378/chest.11-2884..
[37] Korsbæk N,Landt EM,Dahl M.Second-Hand Smoke Exposure Associated with Risk of Respiratory Symptoms,Asthma,and COPD in 20,421 Adults from the General Population[J].J Asthma Allergy,2021,14:1277-1284.DOI:10.2147/JAA.S328748.
[38] Lytras T,Kogevinas M,Kromhout H,et al.Occupational exposures and 20-year incidence of COPD:the European Community Respiratory Health Survey[J].Thorax,2018,73(11):1008-1015.DOI:10.1136/thoraxjnl-2017-211158.
[39] Grahn K,Gustavsson P,Andersson T,et al.Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD):A population-based cohort study in Stockholm,Sweden[J].Environ Res,2021,200:111739.DOI:10.1016/j.envres.2021.111739.
[40] Xie W,Dumas O,Varraso R,et al.Association of Occupational Exposure to Inhaled Agents in Operating Rooms With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses[J].JAMA network open,2021,4(9):e2125749.DOI:10.1001/jamanetworkopen.2021.25749.
[41] World Health Organization.Household air pollution data[EB/OL].[2022-2-12].https://www.who.int/data/gho/data/themes/air-pollution/household-air-pollution.
[42] GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet (London,England),2020,396(10258):1223-1249.DOI:10.1016/S0140-6736(20)30752-2.
[43] Dai X,Bui DS,Perret JL,et al.Exposure to household air pollution over 10 years is related to asthma and lung function decline[J].Eur Respir J,2021,57(1):2000602.DOI:10.1183/13993003.00602-2020.
[44] Yang X,Zhang T,Zhang Y,et al.Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories,1990 to 2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Sci Total Environ,2021,796:148819.DOI:10.1016/j.scitotenv.2021.148819.
[45] Guo C,Zhang Z,Lau A,et al.Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan:a longitudinal,cohort study[J].Lancet Planet Health,2018,2(3):e114-e125.DOI:10.1016/S2542-5196(18)30028-7.
[46] Doiron D,de Hoogh K,Probst-Hensch N,et al.Air pollution,lung function and COPD:results from the population-based UK Biobank study[J].Eur Respir J,2019,54(1):1802140.DOI:10.1183/13993003.02140-2018.
[47] Bernstein AS,Rice MB.Lungs in a warming world:climate change and respiratory health[J].Chest,2013,143(5):1455-1459.DOI:10.1378/chest.12-2384.
[48] Mostafavi B,Diaz S,Piitulainen E,et al.Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency[J].Int J Chron Obstruct Pulmon Dis,2018,13:3689-3698.DOI:10.2147/COPD.S167497.
[49] Silverman EK.Genetics of COPD[J].Annu Rev Physiol,2020,82:413-431.DOI:10.1146/annurev-physiol-021317-121224.
[50] Ragland MF,Benway CJ,Lutz SM,et al.Genetic Advances in Chronic Obstructive Pulmonary Disease.Insights from COPDGene[J].Am J Respir Crit Care Med,2019,200(6):677-690.DOI:10.1164/rccm.201808-1455SO.
[51] 李刚,罗勇,沈礼娟,等.BMI、睡眠、情绪及文化程度与慢性阻塞性肺疾病相关性的研究[J].临床肺科杂志,2016,21(9):1592-1595.
[52] Huang K,Huang K,Xu J,et al.Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease in China:Results from the China Pulmonary Health [CPH] Study[J].Int J Chron Obstruct Pulmon Dis,2021,16:3387-3396.DOI:10.2147/COPD.S328617.
[53] Vikjord SAA,Brumpton BM,Mai X,et al.The association of anxiety and depression with mortality in a COPD cohort.The HUNT study,Norway[J].Respir Med,2020,171:106089.DOI:10.1016/j.rmed.2020.106089.
[54] Zhou M,Wang H,Zeng X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet (London,England),2019,394(10204):1145-1158.DOI:10.1016/S0140-6736(19)30427-1.
[55] European Respiratory Socity on behalf of the Forum of International Respiratory Socities (FIRS).The Global Impact of Respiratory Disease,Second Edition.2017[EB/OL].[2022-2-13].https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf.
[56] Løkke A,Lange P,Lykkegaard J,et al.Economic Burden of COPD by Disease Severity - A Nationwide Cohort Study in Denmark[J].Int J Chron Obstruct Pulmon Dis,2021,16:603-613.DOI:10.2147/COPD.S295388.
[57] Zafari Z,Li S,Eakin MN,et al.Projecting Long-term Health and Economic Burden of COPD in the United States[J].Chest,2021,159(4):1400-1410.DOI:10.1016/j.chest.2020.09.255.